FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells

Signaling mediated by growth factors receptors has long been suggested as one of the key factors responsible for failure of endocrine treatment in breast cancer (BCa). Herein we present that in the presence of tamoxifen, FGFs (Fibroblast Growth Factors) promote BCa cell growth with the strongest eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Turczyk, Lukasz, Kitowska, Kamila, Mieszkowska, Magdalena, Mieczkowski, Kamil, Czaplinska, Dominika, Piasecka, Dominika, Kordek, Radzisław, Skladanowski, Andrzej C., Potemski, Piotr, Romanska, Hanna M., Sadej, Rafal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964976/
https://www.ncbi.nlm.nih.gov/pubmed/28869838
http://dx.doi.org/10.1016/j.neo.2017.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964976/
https://www.ncbi.nlm.nih.gov/pubmed/28869838
http://dx.doi.org/10.1016/j.neo.2017.07.006

Ejemplares similares